Immunization of Patients with Metastatic Melanoma Using Both Class I- and Class Ii-Restricted Peptides from Melanoma-Associated Antigens

Cancer vaccines targeting CD8(+) T cells have been successful in eliciting immunologic responses but disappointing in inducing clinical responses. Strong evidence supports the importance of CD4(+) T cells in “helping” cytotoxic CD8(+) cells in antitumor immunity. We report here on two consecutive cl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Phan, Giao Q., Touloukian, Christopher E., Yang, James C., Restifo, Nicholas P., Sherry, Richard M., Hwu, Patrick, Topalian, Suzanne L., Schwartzentruber, Douglas J., Seipp, Claudia A., Freezer, Linda J., Morton, Kathleen E., Mavroukakis, Sharon A., White, Donald E., Rosenberg, Steven A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2003
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC1679660/
https://ncbi.nlm.nih.gov/pubmed/12843797
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi